BIOMAT Database Logo BIOMAT Database Logo

Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study. 1988

C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Department of Rheumatology, Royal North Shore Hospital, St. Leonards N.S.W., Australia.

Methylprednisolone pulse therapy is often used in patients with severe rheumatoid arthritis (RA). To compare clinical and pharmacokinetic variables of methylprednisolone and oral prednisolone in patients with RA, a controlled crossover study was carried out. Pharmacokinetic variables for methylprednisolone were Vd of 69.9 l, t1/2 of 2.96 h, total plasma clearance of 17.5 l/h. Pharmacokinetic variables for prednisolone were Vd of 47.5 l, t1/2 of 3.08 h and total plasma clearance of 11.3 l/h. During the elimination phase, a secondary rise in methylprednisolone concentration occurred which may be related to enterohepatic circulation. Clinical response to both prednisolone and methylprednisolone was short-lived with neither lasting more than 6 weeks.

UI MeSH Term Description Entries
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
[Pharmacokinetic of prednisolone in patients with rheumatoid arthritis].
January 2002, Terapevticheskii arkhiv,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Comparison of oral prednisolone and intramuscular methylprednisolone in classical rheumatoid arthritis in out-patients.
May 1971, Rheumatology and physical medicine,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis.
September 2000, Immunopharmacology,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Effectiveness of methylprednisolone and prednisolone tertiary-butylacetate intra-articularly in rheumatoid arthritis: a comparative study.
October 1960, Canadian Medical Association journal,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis.
June 1988, Clinical rheumatology,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
A pharmacological and clinical comparison of prednisolone and betamethasone in rheumatoid arthritis.
October 1982, European journal of clinical pharmacology,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
July 1995, Pharmaceutical research,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.
January 2022, Journal of controlled release : official journal of the Controlled Release Society,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Corticosteroid therapy in rheumatoid arthritis; comparative study of effects of prednisone and prednisolone, methylprednisolone, triamcinolone, and dexamethasone.
July 1959, Journal of the American Medical Association,
C J Needs, and M Smith, and J Boutagy, and S Donovan, and D Cosh, and M McCredie, and P M Brooks
Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis.
February 2008, Arthritis and rheumatism,
Copied contents to your clipboard!